Biologics are some of the newest treatment options for atopic dermatitis. Biologics have been around for years as treatment options for many conditions that affect the immune system, but the FDA ...

Biological treatments as an emerging solution Recent advancements in dermatology have introduced biologic medications that target the immune system to reduce inflammation. While these treatments ...

A Texas state lawmaker introduced a bill to amend the state's ban on gender transition procedures or treatment for minors to also apply to adults.

Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...

Health technology is changing the way we treat pain. Orthokine Therapy uses the body’s own healing proteins to reduce ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

This partnership may include potentially developing curative treatments made directly from patient or donor materials, in several ways. Blood centers have supported biologic treatments for over 80 ...

In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.

Researchers have found in a new study that deucravacitinib effectively reduces Psoriasis Area and Severity Index (PASI) and ...

The supplemental Biologics License Application follows dupilumab ... as well as no use of rescue therapy during the 36-week study treatment period. The most common adverse events in the dupilumab ...